OptiNose Inc (OPTN)
1.26
-0.03
(-2.33%)
USD |
NASDAQ |
May 17, 16:00
1.26
0.00 (0.00%)
After-Hours: 20:00
OptiNose Cash from Investing (Quarterly): -0.022M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.022M |
| December 31, 2023 | -0.073M |
| September 30, 2023 | -0.176M |
| June 30, 2023 | -0.079M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.003M |
| September 30, 2022 | -0.01M |
| June 30, 2022 | -0.002M |
| March 31, 2022 | -0.048M |
| December 31, 2021 | -0.024M |
| September 30, 2021 | -0.028M |
| June 30, 2021 | 0.081M |
| March 31, 2021 | -0.091M |
| December 31, 2020 | -0.086M |
| September 30, 2020 | -0.151M |
| Date | Value |
|---|---|
| June 30, 2020 | -0.239M |
| March 31, 2020 | -0.07M |
| December 31, 2019 | -0.072M |
| September 30, 2019 | -0.062M |
| June 30, 2019 | -0.255M |
| March 31, 2019 | -0.168M |
| December 31, 2018 | -0.24M |
| September 30, 2018 | -0.569M |
| June 30, 2018 | -0.499M |
| March 31, 2018 | -0.382M |
| December 31, 2017 | -1.196M |
| September 30, 2017 | -0.499M |
| June 30, 2017 | -0.621M |
| March 31, 2017 | -0.09M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.255M
Minimum
Jun 2019
0.081M
Maximum
Jun 2021
-0.0705M
Average
-0.066M
Median
Cash from Investing (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 98.05M |
| Viking Therapeutics Inc | -459.79M |
| Zevra Therapeutics Inc | 14.79M |
| CytomX Therapeutics Inc | 44.88M |
| Spero Therapeutics Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -22.02M |
| Cash from Financing (Quarterly) | 0.007M |
| Free Cash Flow | -32.43M |
| Free Cash Flow Per Share (Quarterly) | -0.1958 |
| Free Cash Flow to Equity (Quarterly) | -22.47M |
| Free Cash Flow Yield | -22.92% |